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Abstract
The exact mode of transmission of leprosy is not clearly understood; however, many studies have demonstrated active transmission of
leprosy around a source case. Families of ﬁve active leprosy cases and their household contacts were chosen from a high endemic area in
Purulia. Fifty-two soil samples were also collected from different areas of their houses. DNA was extracted from slit-skin smears (SSS) and
soil samples and the Mycobacterium leprae-speciﬁc RLEP (129 bp) region was ampliﬁed using PCR. Molecular typing of M. leprae was
performed for all RLEP PCR-positive samples by single nucleotide polymorphism (SNP) typing and conﬁrmation by DNA sequencing. SSS of
these ﬁve patients and six out of the total 28 contacts were PCR positive for RLEP whereas 17 soil samples out of 52 showed the presence
of M. leprae DNA. SNP typing of M. leprae from all RLEP PCR-positive subjects (patients and smear-positive contacts) and 10 soil samples
showed the SNP type 1 genotype. M. leprae DNA from the ﬁve leprosy patients and the six contacts was further subtyped and the D
subtype was noted in all patients and contacts, except for one contact where the C subtype was identiﬁed. Typing followed by subtyping of
M. leprae clearly revealed that either the contacts were infected by the patients or both patients and contacts had the same source of
infection. It also revealed that the type of M. leprae in the soil in the inhabited areas where patients resided was also of the same type as that
found in patients.
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Introduction
Leprosy is a chronic infectious disease caused by Mycobacte-
rium leprae. It is one of the oldest recorded diseases of
mankind. The changes in the registry pattern after the
implementation of Multi drug therapy (MDT) in the vertical
programme have drastically brought down the prevalence (PR)
of leprosy, whereas the incidence has not come down in many
places in the world [1], including India [2], where a prevalence
of <1/10 000 has been attained. A total of 11 districts with an
incidence rate of >50/100 000 population still exist in Chhat-
tisgarh, Gujarat, Maharashtra, West Bengal, Dadra & Nagar
Haveli, Orissa and Delhi [2]. The global use of MDT seems to
have had only minimal, if any, effect on transmission of the
disease [3] and an adequate explanation for this situation is
lacking. Multibacillary (MB) leprosy patients harbour enormous
numbers of leprosy bacilli and discharge them freely from their
skin, nasal ulcers and saliva [4,5]. Coughing and sneezing can
give rise to formation of droplets and droplet nuclei, which in
turn enter the respiratory system of close contacts. In a house
or in a community such leprosy patients are in contact with
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households and neighbours and have other social relationships.
The contacts of leprosy patients are known to have an
increased risk of contracting leprosy themselves. The esti-
mated risk of leprosy was about nine times higher in
households of patients and four times higher in direct
neighbouring houses of patients compared with households
that had no such contact with patients [6, 7]. The highest risk
of leprosy was associated with households of multibacillary
patients [6]. It has been reported that a single mouthwash of an
MB patient may yield 1.6 million M. leprae [8].
Various studies have suggested that M. leprae can be found
in the environment and may have a role in continuing
transmission of the disease [9–11]. The presence of M. leprae
DNA has also been reported in water samples in Indonesia [9]
and soil samples from high prevalence areas of northern India
[10]. In such endemic areas molecular tools can be of help in
devising techniques for understanding the epidemiology of
leprosy and identifying sources, as well as ﬁnding out the
source of persisting foci of infection. Application of molecular
methods to elicit strain differences within the leprosy bacillus
would be of utmost importance for this purpose. Molecular
typing will make it feasible not only to study the global and
geographical distribution of distinct clones of M. leprae in the
population, but also to explore correlation between the
M. leprae and the type of disease manifested and provide
insight into historical and phylogenetic evolution of the bacillus
[12]. Ultimately these genetic markers may hold the key to
establishing species and strain-speciﬁc markers for identifying
the sources of M. leprae and tracing transmission patterns.
Recently, a complete genome sequence of an isolate from
Tamil Nadu, India (TN strain), helped to develop a polymor-
phic genomic marker for M. leprae. After screening a large
number of M. leprae isolates from different parts of the world,
M. leprae has been classiﬁed into four single nucleotide
polymorphism (SNP) types and 16 subtypes [12,13]. There-
fore, SNPs may hold the promise of establishing species and
strain-speciﬁc markers for identifying the sources of M. leprae
and tracing transmission patterns. The aim of present study
was to detect M. leprae DNA by using PCR and perform typing
based on SNP PCR, followed by restriction enzyme digestion
from slit-skin smears of leprosy patients and their household
contacts and environmental samples.
Materials and Methods
Ethical approval
The study was approved by the Ethical Committee of The
Leprosy Mission, India. Informed consent was obtained from all
the patients and contacts enrolled in the study.
Slit-skin smear samples
Slit-skin smear collection is an invasive procedure where 5 mm
long and 2 mm deep incisions are made on the left and right
earlobe, patches and forearm, after blanching the area between
the thumb and foreﬁnger, and the superﬁcial tissue material is
scraped four times with horizontal strokes of the blade
without any contamination with blood along the skin-slit, and
mixed with 700 lL of 70% ethanol in a micro-centrifuge tube.
Later the samples were transferred to the laboratory and
centrifuged to sediment a pellet of tissue material. After
receiving consent, slit-skin smear samples were collected from
both earlobes of ﬁve active MB leprosy patients and their
household contacts. The contacts selected for the study had
clinical assessment data available from the records of The
Leprosy Mission Hospital, Purulia.
We observed that the mean bacterial index (BI) of all ﬁve
patients was 3+ and six contacts on follow-up were found to be
MBcaseswithanaverageBIof2+. BI is anexpressionof theextent
of bacillary load. It is calculated by counting six to eight stained
smears under the 1009 oil immersion lens. The BI 2+ means at
least one bacillus observed in every 10 ﬁelds of slides under the
microscope andBI 3+ indicates one bacillus in every ﬁeld. Intense
clinical assessment of the contacts in each family revealed a total
of six contacts manifesting cardinal signs of leprosy and 22
contacts without any signs and symptoms of leprosy. Slit-skin
smear samples were collected and AFB staining was performed
for all. (Table2). The slit-skin smear samples (SSS)were collected
during ﬁeld visits in different blocks of Purulia District, West
Bengal, andwere transported in 70% ethanol inmicro-centrifuge
tubes to the laboratory at room temperature (25°C). The tubes
were kept at 4°C until further use.
Environmental samples
Fifty-two soil samples were collected from different places
around the houses of leprosy patients. Soil samples were
collected from areas used for bathing, drinking, sleeping and
sitting and the entrances of the houses. Initially soil was dug (3–
4 inches deep) and 10 gm from each site was collected in clean
plastic containers with the help of a ‘trowel’ and labelled with a
unique speciﬁc code. The collected samples were transported
to the laboratory at room temperature (within 2 days) and
thereafter stored at 4–8°C till further processing.
DNA extraction from slit-skin smears
The Proteinase K Lysis method was used for M. leprae DNA
extraction from slit-skin smear samples [14]. In brief, smears
collected in 1 mL 70% ethanol were centrifuged at 8000 g for
10 min. The supernatant was discarded and the pellet was
air-dried for the removal of ethanol. After ethanol removal,
samples were kept for overnight lysis in lysis buffer (100 mM
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Tris buffer pH 8.5 with 1 mg/mL proteinase K and 0.05%
Tween 20) at 60°C. The Proteinase K was inactivated at 97°C
for 10 min. This lysate preparation was further used for PCR.
DNA extraction from environmental soil samples
These soil samples were processed for DNA extraction by
using a method described earlier [11]. In brief, 100 mg of soil
was weighed and dried in a 1.5-mL microfuge tube; 500 lL
ethanol was added to the tube along with 0.1 mm zirconium
beads and homogenized using a bead beater to ensure and
facilitate lysis of the cells. It was then centrifuged at 8000 g at
4° C and ethanol was discarded. Following this, 250 lL of lysis
buffer (100 mM Tris buffer pH 8.5 with 1 mg/mL proteinase K
and 0.05% Tween 20) was added to the pellet and incubated at
60°C overnight in a water bath. The reaction was terminated
by inactivating Proteinase K at 97°C for 15 mins, and then
30 lL of 10% SDS was added to the tube and incubated at
60°C for 1 h in a water bath. Subsequently, 500 lL of
Tris-EDTA NaCl-PVP buffer (TENP buffer) pH 9.0 was added
and the tube was incubated for 1 h at room temperature with
regular vortexing at 5-min intervals. This was followed by
centrifugation at 3300 g for 10 mins. DNA was precipitated by
adding 70% ethanol and incubated at 20° C for 2–3 h
(preferably overnight). Subsequently, the tubes were centri-
fuged at 8000 g for 15 mins and supernatant discarded. The
pellet was air-dried for about 15–20 min to ensure complete
removal of ethanol. The pellet was resuspended in 50 lL
10 mMTE buffer (pH 8.0) and incubated at 37°C in a water bath
for 1 h to ensure that DNA went into solution. The DNA
solution was then passed through the inhibitor removal resin
columns (Epicentre Biotechnologies, Madison, WI, USA, Cata-
logue no. SR04350) prior to storage at20°C until further use.
PCR ampliﬁcation using the M. leprae-speciﬁc repetitive
element (RLEP) region
PCR ampliﬁcation was carried out in 25 lL of reaction volume
that contained 2 lL of template DNA, primers at a ﬁnal
concentration of 0.5 lM (forward and reverse) and 1X Genei
Mix (Merck, Delhi, India). We used M. leprae-speciﬁc primers
(PS1- TGCATGTCATGGCCTTGAGG; PS2 -CACCGATAC
CAGCGGCAGAA) described previously [15]. The ampliﬁca-
tion was carried out in a thermal cycler (Corbett Research,
Sydney, Australia) using the following conditions: one cycle of
denaturation at 95°C for 5 min followed by 35–45 cycles at
94°C for 30 s, annealing at 58°C for 30 s, extension at 72°C
for 1 min and one cycle of ﬁnal extension at 72°C for 10 min.
PCR product (129 bp) containing ampliﬁed fragments of the
target region was electrophoresed in a 2% agarose gel
(Sigma-Aldrich, New Delhi, India) using Tris-Borate-EDTA
buffer at 100 volts constant voltage.
SNP typing of M. leprae using the PCR-RFLP method
To amplify three SNP loci, 1, 2 and 3 at nucleotide positions
14676, 1642875 and 2935685, M. leprae genomic DNA
(RLEP-positive samples) was ampliﬁed using previously
reported primer sequences [12]. Details of primers used for
genotyping are given in Table 1. Brieﬂy, reactions (20 lL)
typically contained M. leprae DNA from different samples,
10 mM Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mM MgCl2, 1.5 U
Taq DNA polymerase (Qiagen, Delhi, India) and 200 nM each
of forward and reverse primers. PCR was carried out by initial
denaturation at 95°C for 5 min followed by 35 cycles
consisting of denaturation at 95°C for 30 s, annealing at
58°C for 30 s and extension at 72°C for 30 s, with a ﬁnal
extension at 72°C for 10 min in a thermal cycler. The PCR
products were resolved by agarose gel electrophoresis and
detected by ethidium bromide staining.
Restriction digestion assays were carried out according to
the protocol described earlier [16] using SmlI, CviKI-1 and BstUI
(New England Biolabs, Ipswich, MA, USA) for SNP loci 1, 2 and 3,
respectively. The PCRproducts (5 lL)were digestedwith 1 unit
of the enzymes. The SmlI, BstUI and CviKI-1 reactions were
performed at 55, 60 and 37°C, respectively, for 1 h.
The SmlI- and BstUI-uncut and -cut DNAs were subjected
to electrophoresis on 3% agarose gels. The gels were stained
with ethidium bromide and visualized by UV transillumination
using the Gel Documentation System. M. leprae DNA from
Brazilian strain Br 4923 and Thai 53 from Thailand were used
as reference strains for type 4 and type 1, respectively.
PCR used for subtyping of M. leprae
To amplify four SNP subtyping loci 1 at nucleotide positions
8453, 313361, 61425 and 1642879,M. leprae genomicDNAwas
ampliﬁed using previously reported [13] primer sequences as
shown in Table 1. The reactionmix (25 lL) consisted of 10 mM
Tris-HCl (pH 9.0), 50 mM KCl, 1.5 mMMgCl2, 1.5 U TaqDNA
polymerase (Qiagen), 200 nM of each primers and 2 lL DNA
sample. PCR was carried out using initial denaturation at 95°C
TABLE 1. Primers used for genotyping DNA
Locus (Nt) Primer name Oligonucleotide primers
SNP 14676 SNP 14676-F 5′-AATGGAATGCTGGTGAGAGC-3′
SNP 14676-R 5′-CAATGCATGCTAGCCTTAATGA-3′
SNP 1642875 SNP-1642875-F 5′-CTCGTCACAAATCCGAGTTTGAAT-3′
SNP-1642875-R 5′-GTAGTAGTCTTCCAAGTTGTGGTG-3′
SNP 2935685 SNP-2935685-F 5′-ATCTGGTCCGGGTAGGAATC-3′
SNP-2935685-R 5′-ACCGGTGAGCGCACTAAG-3′
SNP 1A 8453 F 5′-GGTCTGCGGACAAGTTGGTA-3′
8453 R 5′-CAATAGCGCTCAGACACGAC-3′
SNP 1B 313361-F 5′-CACCGGAGACAAAGCTGAT-3′
313361-R 5′-CTCGGAGACCAAACTTCTCG-3′
SNP 1C 61425-F 5′-TCGTCAAGCCGAAAGAGTTT-3′
61425-R 5′-CCAGAACACCGAGGGAATAA-3′
SNP 1D 1,642,875 F 5′-TTGAATGCGACCAAACGTACTTTCTG-3′
1,642,875 R 5′-TACCACCGGATCATGGAACCGTC-3′
Primer sequences per Monot et al. [13].
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for 5 min followed by 40 cycles consisting of denaturation at
94°C for 1 min, annealing at 55°C for 1 min and extension at
72°C for 2 min, with a ﬁnal extension at 72°C for 10 min in a
thermal cycler. After ampliﬁcation of PCR products were run on
2% agarose gel by electrophoresis. The amplicons were
outsourced for commercial sequencing (Xplorigen Technolo-
gies, Delhi, India). Sequence data were visualized by using the
Codon Code aligner and quality trimmed sequence data aligned
using Basic Local Alignment Search (tool) (BLAST) from
National Centre for Biotechnology Information (NCBI).
Results
Detection of M. leprae DNA by PCR
Polymerase chain reaction of DNA extracted from SSS samples
of the ﬁve patients and six household contacts showed
ampliﬁcation of RLEP region (Table 2). Similarly, when DNA
extracted from soil samples was screened using PCR (RLEP
region) speciﬁc for M. leprae it was observed that 17 soil
samples out of 52 were positive for M. leprae DNA (Fig. 1).
SNP typing and subtyping of M. leprae DNA from multicase
families:
Eleven SSS samples and ten soil samples that were positive for
Mycobacterium leprae DNA PCR were subjected to polymerase
chain reaction restriction fragment length polymorphism
(PCR-RFLP)-based SNP typing. The samples were ampliﬁed
using primer for locus 3, which gave a 180 bp amplicon. After
restriction of the locus-3 amplicon all samples remained
unrestricted. These samples were then ampliﬁed for locus-2,
which gave a 114 bp amplicon. Restriction of locus-2 was
carried out for these samples and we found a restriction
pattern with 72 bp and 42 bp fragments. It was observed that
all 11 SSS samples and ten soil samples were of SNP
type-1.(Fig. 2) The SNP type for all samples was limited to
SNP type 1with base combination for the nucleotide position
of loci 1, 2, 3 having C,G,A. The 11 SSS samples were further
subtyped. (Table 3). It was observed that samples from all the
patients and their contacts were of the D subtype (Fig. 3),
except for one who had a C subtype (Fig. 4).
Discussion
Transmission of leprosy in family units remains a serious
concern. Transmission of leprosy disease from one person to
another is generally by direct and close contact with an
infectious case. The possibility of indirect transmission
depends mainly upon the viability of the organisms outside
the human body. It has been shown that M. leprae can survive
outside the human body [17]. We had conducted extensive
studies on standardization of the DNA and RNA extraction
protocols in one of our previous studies funded by the Indian
Council of Medical Research, India. We had spiked soil samples
with different numbers of M. smegmatis and carried out DNA
extraction to see workability as well as sensitivity of our
protocols. Further while undertaking this study, we considered
the laboratory observations of Dr Desikan and his colleagues,
who demonstrated the viability of M. leprae in different
TABLE 2. Leprosy patients and their household contacts
Sr.
no Families Relation
Age/
Sex
Bacillary
index (BI)
M. leprae DNA
PCR Results
1 Family 1 Son a 25/M 3+ Positive
2 Father 68/M 2+ Positive
3 Mother 60/F  Negative
4 Brother 29/M  Negative
5 Family 2 Mother a 45/F 3+ Positive
6 Daughter 17/F 2+ Positive
7 Husband 49/M 1+ Positive
8 Son 15/M Cured case Negative
9 Family 3 Son a 23/M 4+ Positive
10 Mother 50/F 1+ Positive
11 Father 55/M  Negative
12 Wife 20/F  Negative
13 Sister 15/F  Negative
14 Brother 27/M  Negative
15 Elder child 5/M  Negative
16 Younger child 7/M  Negative
17 Family 4 Daughter a 15/F 4+ Positive
18 Mother 55/F 1+ Positive
19 Father 65/M  Negative
20 Family 5 Sistera 15/F 4+ Positive
21 Brother 1 26/M 2+ Positive
22 Brother’s wifea 24/F  Negative
23 Father 55/M  Negative
24 Mother 50/F  Negative
25 Brother-2 24/M  Negative
26 Brother’s wifeb 20/F  Negative
27 Brother’s son
(elder)
2/M  Negative
28 Brother’s son
(younger)
5/M  Negative
aMeans case.
bFirst person in the family is primary case whereas the subsequent subjects with
PCR-positive results are the ones who developed disease subsequently.
1   2 3 4 5 6 7 8 9 10 11
129
FIG. 1. Detection of Mycobacterium leprae from environmental sam-
ples targeting the RLEP region. PCR ampliﬁcation of the RLEP region of
M. leprae obtained from the environmental samples from Purulia. PCR
product was electrophoresed on a 2% agarose gel. Samples were: lane
1, negative control; lane 2, positive control; lane 3, 100 bp ladder, lanes
4–11, environmental samples.
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environmental and laboratory conditions. Viability of M. leprae
was veriﬁed by their multiplication in the footpads of normal
mice. After drying in the shade the organisms were viable for
up to 5 months. On wet soil, they remained alive for 46 days.
Kept in saline at room temperature, the organisms lived for
60 days. Surprisingly, on exposure to direct sunlight for 3 h a
day the bacteria survived for 7 days. On refrigeration at 4°C,
the bacteria could be preserved for 60 days. On the other
hand, when kept at 70°C, the bacteria could be maintained in
a living condition for only 28 days. On exposure to antiseptics
such as Savlon (R) and alcohol, the bacteria were rapidly killed.
Based on their observations, we designed this study to identify
and validate similar observations from the environment and
ﬁeld conditions.
All the experiments were performed under controlled
sterile aseptic conditions and all the reagents utilized in the
extraction protocols were mixed and used as sample for PCR
ampliﬁcations in order to determine the possible cross-
contamination of the actual samples with reagents involved
TABLE 3. SNP typing and subtyping from leprosy multicase
families
Families Families Contact Village
PCR
(RLEP
region)
SNP
type
SNP
subtype
1 Family 1 Case Jaipur Positive Type-1 D
Father Positive Type-1 D
2 Family 2 Case Jaipur Positive Type-1 D
Daughter Positive Type-1 D
Husband Positive Type-1 C
3 Family 3 Case Jaipur Positive Type-1 D
Mother Positive Type-1 D
4 Family 4 Case Jhalda Positive Type-1 D
Mother Positive Type-1 D
5 Family 5 Case Jaipur Positive Type-1 D
Brother Positive Type-1 D
PCR-RFLP of locus 2
1 2 3 4 5              6 7 8 9 10
RU R U U R U R U R
72 BP
42 BP
114 BP FIG. 2. Polymerase chain reaction
restriction fragment length polymorphism
of locus-2. Product was electrophoresed
on 4% agarose gel. Samples were: lanes 1,
3, 5, 7, unrestricted sample; restricted 2,
4, 6, 8 and lane 9, Thai strain unrestricted
sample; lane 10 restricted, Thai strain.
FIG. 3. SNP subtype D from slit-skin smears.
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in various protocols. The presence of M. leprae DNA has also
been reported in water samples in Indonesia [9]) and soil
samples from high-prevalence areas of northern India [10,11].
In some studies, it has been suggested that in endemic
countries >50% of leprosy patients may have a history of
intimate contact with an infected person (often a household
contact) [18]. Leprosy patients in non-endemic locales can
identify such contact only 10% of the time [19]. Transmission
of leprosy can be by direct contact or by indirect means
involving fomites but is thought to occur most frequently
through long-term direct contact with an infected host [20].
The present study was therefore conducted in order to
understand the transmission of infection within families with
leprosy living in a rural endemic village. We have collected soil
samples from around the inhabited areas, washing areas,
bathing areas, entrance of the house and sitting areas of the
positive and high bacillary index active MB leprosy cases as
these areas are most likely to get contaminated by patients.
Furthermore, the areas chosen for sample collection were
from high endemic zones of leprosy and were from typical
villages with very poor sanitation and hygiene.
It was also reported in the literature that a single
mouthwash of an MB patient may yield 1.6 million M. leprae
[8]. Other than this, spitting, sneezing, blowing the nose and
shedding of bacteria during bathing, washing, etc., will also
contaminate the soil. Hence we assume the load in the
inhabited areas may have a concentration of M. leprae
sufﬁcient enough to detect using molecular techniques. Soil
contains abundant humic acid and fulvic acid, which are
inhibitory to Taq DNA polymerase and other enzymes used in
PCR assay. We modiﬁed the soil DNA extraction protocol by
incorporating a step of using inhibitor removal resin (Epicen-
ter), which removed the PCR inhibitors from soil samples. To
ensure complete removal of PCR inhibitory substances and
successful DNA extraction, we spiked some of the samples
during processing with Mycobacterium smegmatis and checked
for the DNA using PCR. Further, we used a highly speciﬁc and
sensitive M. leprae gene region called RLEP, which is repeated
28 times in the M. leprae chromosome only and is absent in all
other Mycobacteria.
Experimental negative controls (reagent control) included a
mix of DNA extraction reagents and a mix of PCR buffers, and
PCR was performed with every single test sample and absence
of bands on 2% agarose gels was recorded before conﬁrming
the results. PCR ampliﬁcations using positive control (known
M. leprae DNA) are used as standard reference for the
comparison of the speciﬁc band size. The bias in the
visualizations was taken care of by analysis of the gel images
FIG. 4. SNP subtype C from slit-skin smears.
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by an investigator who was not involved in the study using
Alpha Imager Software (Alpha Innotech Inc, Santa Clara, CA,
USA.).
Several studies have reported the usefulness of polymorphic
markers for M. leprae as an epidemiological tool in differen-
tiation of strains of M. leprae [13,16, 21–24]. Based on the
discovery of three SNPs in M. leprae, it has been previously
reported that there are four major SNP types associated with
different geographical regions around the world. The most
common approach to SNP typing was useful and effective in
molecular epidemiological studies [13]. Further studies on the
presence of the 78 informative SNPs were subsequently
carried out in c. 400 isolates, enabling classiﬁcation of M. leprae
into 16 SNP subtypes of limited geographical distribution that
correlate with the patterns of human migrations and trade
routes [13]. These 16 SNP subtypes were useful for tracking
the transmission of M. leprae and source of infection. It was
earlier reported that by using three microsatellite loci
containing trinucleotide or dinucleotide repeats, extensive
diversity was observed in a cross-sectional survey of 33
patients. Closely related proﬁles were found in members of a
multicase family likely to share a common transmission source
[25]. The present study was based on the detection of
M. leprae from the slit-skin smears of index cases and their
household contacts and the samples from their surrounding
environments.
We have detected M. leprae DNA from the SSS and soil
samples by using the (repetitive element) RLEP-PCR method.
We found M. leprae DNA from soil samples speciﬁcally in
areas where active leprosy patients reside. This suggests that
shedding of M. leprae from active MB leprosy cases in
residential areas may lead to a susceptible person being
indirectly exposed to and/or infected with M. leprae. All the
PCR-positive SSS samples analyzed by SNP typing were of SNP
type 1. M. leprae DNA from the patients and their household
contacts was further subtyped and it was noted that the 1D
subtype was predominant in these families, which strongly
indicated that the spread of infection in the families was from
active source cases of MB leprosy. Further, it was also
observed that a similar subtype 1D was present in the majority
of the multicase families, including three families from the
Jaipur region (an index case and his father in one family, an
index case and mother in another family, and an index case and
her brother in the third family). Similarly, we found the same
1D subtype in an index case and his mother from the Jhalda
region of Purulia. However, in one of the families from the
Jaipur region we observed that an index case and her daughter
had a similar 1D subtype but one contact had a 1C subtype,
indicating that the source of infection was different from the
other two cases and infection might have occurred from other
source (outside the home) (Table 3). Thus the present study
with subtyping of M. leprae clearly highlights the possible
source of infection and that most of the contacts were either
infected by the patients and/or both patients and contacts had
the same source of infection from the environment.
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